Literature DB >> 26566064

AASLD guidelines for treatment of chronic hepatitis B.

Norah A Terrault1, Natalie H Bzowej2, Kyong-Mi Chang3, Jessica P Hwang4, Maureen M Jonas5, M Hassan Murad6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26566064      PMCID： PMC5987259          DOI： 10.1002/hep.28156

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  122 in total

1.  Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

Authors:  Ting-Tsung Chang; Yun-Fan Liaw; Shun-Sheng Wu; Eugene Schiff; Kwang-Hyub Han; Ching-Lung Lai; Rifaat Safadi; Samuel S Lee; Waldemar Halota; Zachary Goodman; Yun-Chan Chi; Hui Zhang; Robert Hindes; Uchenna Iloeje; Suzanne Beebe; Bruce Kreter
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.

Authors:  Stefan Mauss; Florian Berger; Natalie Filmann; Dietrich Hueppe; Julia Henke; Petra Hegener; Christoph Athmann; Guenther Schmutz; Eva Herrmann
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

3.  Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

Authors:  Stephanos J Hadziyannis; Nicolaos C Tassopoulos; E Jenny Heathcote; Ting-Tsung Chang; George Kitis; Mario Rizzetto; Patrick Marcellin; Seng Gee Lim; Zachary Goodman; Jia Ma; Sarah Arterburn; Shelly Xiong; Graeme Currie; Carol L Brosgart
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

4.  Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.

Authors:  Thomas Berg; Fabien Zoulim; Bernd Moeller; Huy Trinh; Patrick Marcellin; Sing Chan; Kathryn M Kitrinos; Phillip Dinh; John F Flaherty; John G McHutchison; Michael Manns
Journal:  J Hepatol       Date:  2013-12-01       Impact factor: 25.083

5.  Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.

Authors:  Christian M Lange; Jörg Bojunga; Wolf Peter Hofmann; Katrin Wunder; Ulrike Mihm; Stefan Zeuzem; Christoph Sarrazin
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

6.  Side effects of long-term oral antiviral therapy for hepatitis B.

Authors:  Robert J Fontana
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.

Authors:  Jeffrey B Schwimmer; Winston Dunn; Gregory J Norman; Perrie E Pardee; Michael S Middleton; Nanda Kerkar; Claude B Sirlin
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

8.  Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naïve patients with chronic hepatitis B: a multicenter real-life study.

Authors:  Ayse Batirel; Ertugrul Guclu; Ferhat Arslan; Funda Kocak; Oguz Karabay; Serdar Ozer; Munevver Turanli; Ali Mert
Journal:  Int J Infect Dis       Date:  2014-10-05       Impact factor: 3.623

9.  Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.

Authors:  Tony Andreani; Lawrence Serfaty; Djamila Mohand; Salem Dernaika; Dominique Wendum; Olivier Chazouillères; Raoul Poupon
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-11       Impact factor: 11.382

10.  Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus.

Authors:  Yali Hu; Jie Chen; Jian Wen; Chenyu Xu; Shu Zhang; Biyun Xu; Yi-Hua Zhou
Journal:  BMC Pregnancy Childbirth       Date:  2013-05-24       Impact factor: 3.007
View more
  519 in total

Review 1.  Management of hepatitis B in special populations.

Authors:  Kali Zhou; Norah Terrault
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-06-08       Impact factor: 3.043

2.  Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18-49 Years With Risk Factors for Hepatitis B Virus Infection-United States, 2003-2014.

Authors:  Hope King; Jian Xing; Hazel D Dean; Deborah Holtzman
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

3.  APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients.

Authors:  Jia-Horng Kao; Tung-Hung Su; Wen-Juei Jeng; Qin Ning; Tai-Chung Tseng; Yoshiyuki Ueno; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2021-07-23       Impact factor: 6.047

4.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

5.  Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.

Authors:  Nagraj Mani; Andrew G Cole; Janet R Phelps; Andrzej Ardzinski; Kyle D Cobarrubias; Andrea Cuconati; Bruce D Dorsey; Ellen Evangelista; Kristi Fan; Fang Guo; Haitao Guo; Ju-Tao Guo; Troy O Harasym; Salam Kadhim; Steven G Kultgen; Amy C H Lee; Alice H L Li; Quanxin Long; Sara A Majeski; Richeng Mao; Kevin D McClintock; Stephen P Reid; Rene Rijnbrand; Nicholas M Snead; Holly M Micolochick Steuer; Kim Stever; Sunny Tang; Xiaohe Wang; Qiong Zhao; Michael J Sofia
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

6.  Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?

Authors:  Kali Zhou; Norah Terrault
Journal:  AME Med J       Date:  2018-02-10

Review 7.  Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.

Authors:  Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

8.  Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis.

Authors:  Aida Siyahian; Saad Ullah Malik; Adeela Mushtaq; Carol L Howe; Aneela Majeed; Tirdad Zangeneh; Samar Iftikhar; Shahid Habib; Umar Zahid; Irbaz Bin Riaz; Zabih Warraich; Warda Faridi; Faiz Anwer
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-12       Impact factor: 5.742

9.  Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.

Authors:  Neil D Shah; Meritxell Ventura-Cots; Juan G Abraldes; Mohamed Alboraie; Ahmad Alfadhli; Josepmaria Argemi; Ester Badia-Aranda; Enrique Arús-Soler; A Sidney Barritt; Fernando Bessone; Marina Biryukova; Flair J Carrilho; Marlen Castellanos Fernández; Zaily Dorta Guiridi; Mohamed El Kassas; Teo Eng-Kiong; Alberto Queiroz Farias; Jacob George; Wenfang Gui; Prem H Thurairajah; John Chen Hsiang; Azra Husić-Selimovic; Vasily Isakov; Mercy Karoney; Won Kim; Johannes Kluwe; Rakesh Kochhar; Narendra Dhaka; Pedro Marques Costa; Mariana A Nabeshima Pharm; Suzane K Ono; Daniela Reis; Agustina Rodil; Caridad Ruenes Domech; Federico Sáez-Royuela; Christoph Scheurich; Way Siow; Nadja Sivac-Burina; Edna Solange Dos Santos Traquino; Fatma Some; Sanjin Spreckic; Shiyun Tan; Julio Vorobioff; Andrew Wandera; Pengbo Wu; Mohamed Yacoub; Ling Yang; Yuanjie Yu; Nerma Zahiragic; Chaoqun Zhang; Helena Cortez-Pinto; Ramon Bataller
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-29       Impact factor: 11.382

10.  Hepatitis B in Pregnancy.

Authors:  Tram T Tran
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.